Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

First in Human Response of BCL-2 Inhibitor Venetoclax in T-Cell Prolymphocytic Leukemia

Bernd Boidol, Christoph Kornauth, MD, Emiel van der Kouwe, Nicole Prutsch, Lukas Kazianka, MD, Gregor Hoermann, MD, Georg Hopfinger, MD, Alexander Hauswirth, MD, Marie-Bernadette Aretin, Wolfgang R. Sperr, MD, Peter Valent, MD, Ingrid Simonitsch-Klupp, MD, Richard Morrigl, PhD, Olaf Merkel, PhD, Lukas Kenner, MD, Ulrich Jaeger, MD, Stefan Kubicek, PhD, Philipp Bernhard Staber, MD PhD

Blood (2017) 130 (Supplement 1): 575.

https://doi.org/10.1182/blood.V130.Suppl_1.575.575

Published: 2017

Journal Articles

Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies

Blood (2017) 130 (Supplement 1): 855.

https://doi.org/10.1182/blood.V130.Suppl_1.855.855

Published: 2017

Journal Articles

Digital Droplet PCR: Next Generation KIT D816V Testing As Advanced Tool for Diagnosis and Prognostication in Mastocytosis

Greiner Georg, MD PhD, Michael Gurbisz, MSc, Franz Ratzinger, MD, Nadine Witzeneder, MSc, Ingrid Simonitsch-Klupp, MD, Gerlinde Mitterbauer-Hohendanner, MD, Matthias Mayerhofer, MD, Leonhard Muellauer, MD PhD, Wolfgang R. Sperr, MD, Peter Valent, MD, Gregor Hoermann, MD

Blood (2017) 130 (Supplement 1): 2927.

https://doi.org/10.1182/blood.V130.Suppl_1.2927.2927

Published: 2017

Journal Articles

Cardiovascular Scoring and Age-Related Mutations Predict the Occurrence of Adverse Vascular Events in CML Patients during Nilotinib Therapy

Emir Hadzijusufovic, DVM, Gregor Hoermann, MD, Susanne Herndlhofer, Wolfgang R. Sperr, MD, Bernd Jilma, MD, Gerit H. Schernthaner, MD, Peter Valent, MD

Blood (2017) 130 (Supplement 1): 1619.

https://doi.org/10.1182/blood.V130.Suppl_1.1619.1619

Published: 2017

Journal Articles

JAK2-Inhibitor Therapy Associated Lymphomas in Myelofibrosis: Distinct Clinico-Pathological Features Recapitulated in a Mouse Model

Blood (2017) 130 (Supplement 1): 1643.

https://doi.org/10.1182/blood.V130.Suppl_1.1643.1643

Published: 2017

Journal Articles

Integrated ATAC-Seq and Chemosensitivity Profiling Identifies Rational Drug Combinations in Ibrutinib-Treated CLL Patients

Blood (2017) 130 (Supplement 1): 800.

https://doi.org/10.1182/blood.V130.Suppl_1.800.800

Published: 2017

Journal Articles

CCL-2 Is a KIT D816V-Dependent Modulator of Bone Marrow Remodeling and Microenvironmental Alterations in Systemic Mastocytosis

Georg Greiner, MD, Nadine Witzeneder, Klaus Schmetterer, MD PhD, Theresia Popow-Kraupp, MD, Wolfgang R Sperr, MD, Peter Valent, MD, Matthias Mayerhofer, MD, Gregor Hoermann, MD PhD

Blood (2015) 126 (23): 1635.

https://doi.org/10.1182/blood.V126.23.1635.1635

Published: 2015

Journal Articles

A Novel Fusion Gene NDEL1-Pdgfrb in a Patient with JMML with a New Variant of TKI-Resistant Mutation in the Kinase Domain of PDGFRβ

Konstantin Byrgazov, PhD, Renate Kastner, PhD, Michael Dworzak, MD, Gregor Hoermann, MD PhD, Oskar A. Haas, MD, Raphael Ulreich, MD, Christian E. Urban, MD, Oliver D. Hantschel, PhD, Peter Valent, MD, Thomas Lion, MD PhD

Blood (2014) 124 (21): 613.

https://doi.org/10.1182/blood.V124.21.613.613

Published: 2014

Journal Articles

Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome+ CML

Blood (2014) 124 (21): 1800.

https://doi.org/10.1182/blood.V124.21.1800.1800

Published: 2014

Journal Articles

Identification of CAR As a Novel Mediator of Erythroid Differentiation and Migration That Is Specifically Downregulated in Erythropoietic Progenitor Cells in Patients with MDS

Karin Bauer, PhD, Sigrid Machherndl-Spandl, MD, Susanne Suessner, MSc, Martin Danzer, MSc, Johannes Pröll, PhD, Jeroen Lauf, Gregor Eisenwort, MD PhD, Wolfgang R. Sperr, MD, Hans-Ulrich Klein, PhD, Gregor Hoermann, MD PhD, Norman Häfner, PhD, Marie Bene, PharmSciD, PhD, Uwe Platzbecker, MD, Ansgar Weltermann, MD, Christian Gabriel, MD, Ulrich Germing, Peter Bettelheim, MD, Peter Valent, MD

Blood (2014) 124 (21): 1570.

https://doi.org/10.1182/blood.V124.21.1570.1570

Published: 2014

Journal Articles

Identification of a Neoplastic Stem Cell in Human Mast Cell Leukemia

Gregor Eisenwort, MD PhD, Barbara Peter, D.V.M., Katharina Blatt, MSc, PhD, Sabine Cerny-Reiterer, DVM, Gregor Hoermann, MD PhD, Irina Sadovnik, MSc, Martin Bilban, MD, Thomas Rülicke, D.V.M., Michael Willmann, D.V.M., Juliana Schwaab, MD, Andreas Reiter, MD, Wolfgang R Sperr, MD, Christine Mannhalter, PhD, Peter Valent, MD

Blood (2014) 124 (21): 817.

https://doi.org/10.1182/blood.V124.21.817.817

Published: 2014

Journal Articles

Identification of Basophils as Source of Hepatocyte Growth Factor (HGF) In CML: a Potential Trigger of Disease Acceleration.

Sabine Cerny-Reiterer, DVM, Karl J. Aichberger, MD, Harald Herrmann, MD, Gregor Hoermann, MD, Barbara Peter, MVM, Leonhard Muellauer, MD, Matthias Mayerhofer, MD, Peter Valent, MD

Blood (2010) 116 (21): 1202.

https://doi.org/10.1182/blood.V116.21.1202.1202

Published: 2010

Journal Articles

Identification of Oncostatin M as a Novel KIT D816V-Dependent Cytokine in Neoplastic Human Mast Cells.

Gregor Hoermann, MD, Sabine Cerny-Reiterer, MD, Andrea Perne, MD, Miriam Klauser, Leonhard Muellauer, MD, Peter Valent, MD, Matthias Mayerhofer, MD

Blood (2009) 114 (22): 213.

https://doi.org/10.1182/blood.V114.22.213.213

Published: 2009

NARROW

First in Human Response of BCL-2 Inhibitor Venetoclax in T-Cell Prolymphocytic Leukemia

Next-Generation Functional Drug Screening for Patients with Aggressive Hematologic Malignancies

Digital Droplet PCR: Next Generation KIT D816V Testing As Advanced Tool for Diagnosis and Prognostication in Mastocytosis

Cardiovascular Scoring and Age-Related Mutations Predict the Occurrence of Adverse Vascular Events in CML Patients during Nilotinib Therapy

JAK2-Inhibitor Therapy Associated Lymphomas in Myelofibrosis: Distinct Clinico-Pathological Features Recapitulated in a Mouse Model

Integrated ATAC-Seq and Chemosensitivity Profiling Identifies Rational Drug Combinations in Ibrutinib-Treated CLL Patients

CCL-2 Is a KIT D816V-Dependent Modulator of Bone Marrow Remodeling and Microenvironmental Alterations in Systemic Mastocytosis

A Novel Fusion Gene NDEL1-Pdgfrb in a Patient with JMML with a New Variant of TKI-Resistant Mutation in the Kinase Domain of PDGFRβ

Further Evaluation of Pro-Atherogenic and Anti-Angiogenic Effects of Nilotinib in Mice and in Patients with Ph-Chromosome+ CML

Identification of CAR As a Novel Mediator of Erythroid Differentiation and Migration That Is Specifically Downregulated in Erythropoietic Progenitor Cells in Patients with MDS

Identification of a Neoplastic Stem Cell in Human Mast Cell Leukemia

Identification of Basophils as Source of Hepatocyte Growth Factor (HGF) In CML: a Potential Trigger of Disease Acceleration.

Identification of Oncostatin M as a Novel KIT D816V-Dependent Cytokine in Neoplastic Human Mast Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only